NORTH
CHICAGO, Ill., Sept. 7,
2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in the Morgan Stanley 20th Annual Global Healthcare
Conference on Tuesday, September 13,
2022. Rob Michael, vice
chairman and president, Jeff
Stewart, executive vice president, commercial operations,
and Neil Gallagher, vice president
development and chief medical officer will present at 9:35 a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit us at www.abbvie.com. Follow @abbvie on Twitter,
Facebook, Instagram, YouTube and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-healthcare-conference-301618670.html
SOURCE AbbVie